Stoke Therapeutics, Inc.

General ticker "STOK" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $542.3M (TTM average)

Stoke Therapeutics, Inc. follows the US Stock Market performance with the rate: 4.4%.

Estimated limits based on current volatility of 3.3%: low 9.39$, high 10.02$

Factors to consider:

  • Earnings expected soon, date: 2025-05-05 bmo
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [7.00$, 18.49$]
  • 2025-12-31 to 2026-12-31 estimated range: [4.41$, 12.43$]

Financial Metrics affecting the STOK estimates:

  • Negative: Non-GAAP EPS, $ of -1.68 <= 0.04
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -11.70 <= 1.79
  • Negative: negative Operating income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term STOK quotes

2025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-02678910
Price $

Long-term STOK plot with estimates

4681012141618Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.6−0.4−0.20
STOKS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $12.40MM $8.78MM $36.55MM
Operating Expenses $116.76MM $123.55MM $137.93MM
Operating Income $-104.36MM $-114.77MM $-101.37MM
Non-Operating Income $3.29MM $10.07MM $12.39MM
R&D Expense $77.84MM $82.23MM $89.13MM
Income(Loss) $-101.07MM $-104.70MM $-88.98MM
Profit(Loss)* $-93.11MM $-104.70MM $-88.98MM
Stockholders Equity $184.85MM $159.56MM $229.02MM
Inventory $10.93MM $0.00MM $0.00MM
Assets $256.07MM $228.34MM $271.56MM
Operating Cash Flow $-31.87MM $-81.07MM $-86.85MM
Capital expenditure $3.96MM $1.62MM $0.20MM
Investing Cash Flow $-45.88MM $105.95MM $-107.47MM
Financing Cash Flow $46.41MM $53.01MM $131.09MM
Earnings Per Share** $-2.39 $-2.38 $-1.65

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.